Carolean™ (Carob & Nopal Appetite Control)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Carolean™ is a synergistic proprietary complex of carob (Ceratonia siliqua) and nopal (Opuntia ficus-indica) developed by Nexira (France) for appetite control and weight management. Patent-pending formulation. Distinguished by rapid satiety mechanism (~70% viscosity achieved within 15 minutes of ingestion based on in vitro viscosity measurements), a 47% reduction in food intake reported in a 2024 animal (in vivo) study (not yet confirmed in humans), and synergistic action via gastric emptying delay. Used in weight management food supplements.

Studied Dose 3 g/day (dose used in preclinical animal/in vitro research); typical use as recommended by product
Active Compound Carob (galactomannan, polyphenols) + Nopal (soluble fiber, mucilage)

Benefits

Appetite Control / Reduced Food Intake

A 2024 Nexira animal (in vivo) study reported a 47% reduction in food intake at a 3 g/day human-equivalent dose over 4 weeks. This is a preclinical result that has not been confirmed in humans. Proposed mechanism: slowing of gastric emptying to prolong fullness.

Rapid Satiety Onset

In simulated ingestion conditions, Carolean™ achieves 70% of maximum viscosity within 15 minutes of ingestion — faster than recognized market satiety ingredients. This reflects an in vitro viscosity measurement in simulated conditions, not a demonstrated human satiety comparison.

Gastric Emptying Delay

The same 2024 Nexira animal study reported slowing of gastric emptying in single-dose and prolonged-use scenarios. Human confirmation is not yet available.

Synergistic Action

Carob (galactomannan) and Nopal (soluble fiber/mucilage) work synergistically — different fiber types with complementary water-binding and gel-forming properties create enhanced satiety effect vs either alone.

Weight Management Adjunct

Reduced food intake supports caloric deficit; useful adjunct in comprehensive weight management. Effects via appetite mechanism rather than metabolism.

Mechanism of action

1

Gastric Emptying Delay

Soluble fibers from carob and nopal create gel-like matrix in stomach that slows gastric emptying — prolongs feeling of fullness, reduces subsequent food intake. Foundation for appetite control.

2

Carob Galactomannan

Carob (locust bean gum) provides galactomannan — soluble fiber with strong water-binding and gel-forming properties. Mannose:galactose ratio of 4:1.

3

Nopal Soluble Fiber and Mucilage

Nopal provides additional soluble fiber, mucilage, and pectin compounds — complementary to carob with different viscosity profile.

4

Patent-Pending Synergistic Formulation

Specific ratios and processing developed by Nexira to optimize satiety kinetics — patent-pending status reflects novel formulation approach. Effects greater than additive of individual components.

Clinical trials

1
Carolean™ Appetite Control

In vivo study of Carolean™ at 3 g/day equivalent for 4 weeks on appetite, gastric emptying, and food intake.

Animal in vivo model.

Significant slowing of gastric emptying in single and prolonged use; 47% average reduction in food intake. Suggested a dose-related effect in this preclinical animal model; not established in humans.

2
Carolean™ Satiety Kinetics — Nexira

Simulated ingestion conditions (temperature, pH) measuring viscosity development over time.

In vitro / simulated GI conditions.

70% of maximum viscosity reached within 15 minutes — an in vitro viscosity observation, not an established human satiety advantage.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (gas, bloating) — possible with rapid introduction or high doses.
Allergic reactions to legumes (carob is legume) possible.
Allergic reactions to cactus rare.
Constipation if inadequate fluid intake.
Esophageal obstruction risk if taken without water (any soluble fiber).

Important Drug interactions

Fiber may delay medication absorption — separate by 1-2 hours.
Diabetes medications — modest hypoglycemic potentiation via gastric emptying delay.
Cholesterol medications — modest additive effects.
Pregnancy — limited safety data; avoid concentrated supplementation in pregnancy.
Lactation — limited data; avoid supplementation.

Frequently asked questions about Carolean™ (Carob & Nopal Appetite Control)

What is Carolean?

Carolean™ is a synergistic proprietary complex of carob (Ceratonia siliqua) and nopal (Opuntia ficus-indica) developed by Nexira (France) for appetite control and weight management. Patent-pending formulation.

What is Carolean used for?

Carolean is researched primarily for Weight Management. A 2024 Nexira animal (in vivo) study reported a 47% reduction in food intake at a 3 g/day human-equivalent dose over 4 weeks. This is a preclinical result that has not been confirmed in humans.

What is the recommended dosage of Carolean?

The clinically studied dose is 3 g/day (dose used in preclinical animal/in vitro research); typical use as recommended by product Always follow the product label and check with a healthcare provider for personal advice.

Is Carolean safe, and does it have side effects?

For most healthy adults, Carolean is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress (gas, bloating) — possible with rapid introduction or high doses. It may also interact with some medications. Carolean is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Carolean interact with any medications?

Possible interactions include: Fiber may delay medication absorption — separate by 1-2 hours. Diabetes medications — modest hypoglycemic potentiation via gastric emptying delay. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Carolean?

NutraSmarts rates the evidence for Carolean as Limited (2 out of 5). It is backed by 2 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Wanders AJ, Feskens EJ, Jonathan MC, Schols HA, de Graaf C, Mars M Pectin is not pectin: a randomized trial on the effect of different physicochemical properties of dietary fiber on appetite and energy intake. Physiology & Behavior. 2014;128:212-19. doi: 10.1016/j.physbeh.2014.02.007.PubMedUsed to support: Randomized crossover trial in healthy adults demonstrating that high-viscosity dietary fiber (pectin/gel-forming fiber, the same physicochemical class as the fiber in carob and nopal) significantly reduced appetite and ad libitum energy intake compared to low-viscosity fiber. Supports Rapid Satiety Onset and Gastric Emptying Delay benefits; evidence is for the viscous fiber mechanism shared by carob and nopal components, not for CaroLean™ brand specifically.
  2. Wanders AJ, Jonathan MC, van den Borne JJ, Mars M, Schols HA, Feskens EJ, de Graaf C The effects of bulking, viscous and gel-forming dietary fibres on satiation. The British Journal of Nutrition. 2013;109(7):1330-7. doi: 10.1017/S0007114512003145.PubMedUsed to support: Randomized human trial showing gel-forming dietary fibers (viscous polysaccharides including galactomannans as found in carob) significantly increased satiation scores during and after a meal. Supports Appetite Control / Reduced Food Intake, Rapid Satiety Onset, and Synergistic Action benefits; evidence is for the fiber-mechanism class, not CaroLean™ brand specifically.